@hannahrosers As someone who practiced when women were less common, at least in surgical specialties, my opinion is that women are absolutely helping medicine. You and your colleagues should keep on excelling. That attending is on the wrong side of history IMO.
@CindyCindyhock I based my recommendation on good science, published in peer-reviewed journals. What would get me to change my mind is better science, also published in peer-reviewed journals.
What would get you to change your mind?
Check out the Patient Activated Learning System—a publicly available resource designed to provide engaging, easily understood, and well-researched information by doctors for people who want to know more their #health, #medicines, and #diseases.
https://t.co/vvFndE9nEy
@igv I appreciate your good faith. My view is that when there is a potential for harm, the benefit must be proven in order to recommend its use. This is particularly the case when taken by many people to prevent problems, so there is no potential for improving symptoms.
@GraceAngelic1@PhillyPharmaBoy@leekatzmarek@KSTP If you aren’t eligible, because you are fully vaccinated, young, and healthy, then the overwhelming majority of people will do well with COVID-19. There are no effective treatments for this group. Paxlovid is not helpful.
@GraceAngelic1@leekatzmarek@KSTP Your doctor, and any doctor prescribing ivermectin for COVID, was not practicing the standard of care. Anecdotes are not data. Most people will get better from COVID-19. And of course a safe dose isn’t harmful. That’s why we call it a safe dose. It’s just not effective.
@GraceAngelic1@leekatzmarek@KSTP Newspaper editors, not authors, write headlines. The headline should have been “ivermectin not safe or effective for COVID-19”.
@GraceAngelic1@leekatzmarek@KSTP You can find out how to tell if a physician is funded by pharmaceutical companies. I explain how here: https://t.co/8D52RqazUF
@GraceAngelic1@PhillyPharmaBoy@leekatzmarek@KSTP 6. A recent study showed ivermectin increases the risk of emergency department visit, hospitalization, or death by 39%, but this was not statistically significant and may have been due to chance.
@GraceAngelic1@PhillyPharmaBoy@leekatzmarek@KSTP 3. Physicians shouldn’t take care of their family members, and my family is off limits for this conversation. But people with symptomatic COVID-19 and who are not sick enough to be hospitalized should be treated with ritonavir/nirmatrelvir if they meet eligibility criteria.
@GraceAngelic1@PhillyPharmaBoy@leekatzmarek@KSTP 1. For ivermectin and COVID-19, there is no effective dose. There are safe doses, such as those used for parasitic infections, but these are not effective against COVID.